Xuan Yang

2.2k citations
34 papers · 1.3k indexed · 1 hit paper · h-index 20
Topics
Cancer-related molecular mechanisms research (10 papers)MicroRNA in disease regulation (7 papers)RNA modifications and cancer (6 papers)

In The Last Decade

Xuan Yang

33 papers receiving 1.3k citations

Hit Papers

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment an...20222026202320242022255075100

Peers

Xuan Yang
Comparison fields: 5 of 104
  • Molecular Biology 898
  • Cancer Research 672
  • Oncology 204
  • Immunology 148
  • Epidemiology 137
Replace Stefan David with:
Stefan David United States
Huahong Xie China
Ting Wei China
Ashley M. Mohr United States
Yixin Xu China
Pengcheng Jiang China
Zhongwei Lv China
Jun Song China
Xuan Yang relative to Stefan David United States Stefan David's profile →
Citations per field
00.5×4.2×
Stefan David · 1×
Citations per year

Countries citing papers authored by Xuan Yang

Since Specialization
Citations

This map shows the geographic impact of Xuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Yang more than expected).

Fields of papers citing papers by Xuan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Yang. The network helps show where Xuan Yang may publish in the future.

Co-authorship network of co-authors of Xuan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Yang. A scholar is included among the top collaborators of Xuan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Yang. Xuan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 14
4 5
5 2
6
PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinomabreakdown →
114
7 20
8 178
9 18
10 45
11 174
12 122
13 20
14 42
15 19
16 18
17 5
18 38
19 121
20 49

About Xuan Yang

Xuan Yang is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (672 citations), Molecular Biology (898 citations) and Oncology (204 citations). Xuan Yang has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Chuanyuan Wei, Rui Peng, Pengfei Zhang, Jia‐Cheng Lu, Jia Fan, Ai‐Wu Ke, Guo‐Ming Shi, Chao Gao, Xiaoyong Huang and Jiabin Cai. Their work appears in journals such as Oncogene, Journal of Neurochemistry and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026